Bergerot PG - Search Results

1

Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy.

Bergerot CD, Bergerot PG, Philip EJ, Hsu JA, Dizman N, Vaishampayan U, Dorff T, Pal SK. Bergerot CD, et al. Among authors: bergerot pg. J Immunother Cancer. 2019 Mar 12;7(1):71. doi: 10.1186/s40425-019-0557-5. J Immunother Cancer. 2019. PMID: 30867071 Free PMC article.

2

Tivozanib: current status and future directions in the treatment of solid tumors.

Pal SK, Bergerot PG, Figlin RA. Pal SK, et al. Among authors: bergerot pg. Expert Opin Investig Drugs. 2012 Dec;21(12):1851-9. doi: 10.1517/13543784.2012.733695. Epub 2012 Sep 26. Expert Opin Investig Drugs. 2012. PMID: 23013465 Free PMC article. Review.

3

Preoperative therapy for localized prostate cancer: a comprehensive overview.

Hu J, Hsu J, Bergerot PG, Yuh BE, Stein CA, Pal SK. Hu J, et al. Among authors: bergerot pg. Maturitas. 2013 Jan;74(1):3-9. doi: 10.1016/j.maturitas.2012.10.012. Epub 2012 Nov 14. Maturitas. 2013. PMID: 23158077 Free PMC article. Review.

4

Impact of age on treatment trends and clinical outcome in patients with metastatic renal cell carcinoma.

Pal SK, Hsu J, Hsu S, Hu J, Bergerot P, Carmichael C, Saikia J, Liu X, Lau C, Twardowski P, Figlin RA, Yuh BF. Pal SK, et al. J Geriatr Oncol. 2013 Apr;4(2):128-33. doi: 10.1016/j.jgo.2012.11.001. J Geriatr Oncol. 2013. PMID: 23646100 Free PMC article.

5

Developing a Clear Path Forward for Non-Clear-Cell Renal Carcinoma.

Pal SK, Karam JA, Bergerot P, Agarwal N. Pal SK, et al. J Clin Oncol. 2016 Nov 10;34(32):3825-3826. doi: 10.1200/JCO.2016.69.3572. J Clin Oncol. 2016. PMID: 27601540 No abstract available.

6

Quality Oncology Practice Initiative Can Guide and Improve Oncology Providers' Training in Brazil.

Bergerot CD, Philip EJ, Bergerot PG, Elias S, Guimarães DP, Forones NM, Baiocchi OCCG, Batista NA, De Domenico EBL. Bergerot CD, et al. Among authors: bergerot pg. J Glob Oncol. 2016 Sep 21;3(3):189-193. doi: 10.1200/JGO.2016.006148. eCollection 2017 Jun. J Glob Oncol. 2016. PMID: 28717759 Free PMC article.

7

Case Discussion: Systemic Therapy for Metastatic Renal Cell Carcinoma.

Maia MC, Bergerot P, Pal SK. Maia MC, et al. Eur Urol Focus. 2016 Dec 15;2(6):579-581. doi: 10.1016/j.euf.2017.02.008. Epub 2017 Mar 1. Eur Urol Focus. 2016. PMID: 28723488

8

Exceptional Response to Nivolumab Rechallenge in Metastatic Renal Cell Carcinoma with Parallel Changes in Genomic Profile.

Dizman N, Bergerot P, Bergerot C, Lanman RB, Raymond VM, Banks KC, Jones J, Pal SK. Dizman N, et al. Eur Urol. 2018 Feb;73(2):308-310. doi: 10.1016/j.eururo.2017.08.006. Epub 2017 Aug 24. Eur Urol. 2018. PMID: 28844598 No abstract available.

9

Sarcomatoid Renal Cell Carcinoma: The Apple Doesn't Fall Far from the Tree.

Bergerot P, Agarwal N, Pal SK, Jones J. Bergerot P, et al. Clin Cancer Res. 2017 Nov 1;23(21):6381-6383. doi: 10.1158/1078-0432.CCR-17-2039. Epub 2017 Sep 14. Clin Cancer Res. 2017. PMID: 28912138

10

Current systemic therapies for metastatic renal cell carcinoma in older adults: A comprehensive review.

Maia MC, Adashek J, Bergerot P, Almeida L, Dos Santos SF, Pal SK. Maia MC, et al. J Geriatr Oncol. 2018 May;9(3):265-274. doi: 10.1016/j.jgo.2017.11.011. Epub 2017 Dec 15. J Geriatr Oncol. 2018. PMID: 29249644 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters